Answers are grounded in this paper and cite their sources.
Summary: Diabetic peripheral neuropathy: Nerve conduction studies before, during and after carbamazepine therapy. A. K. Chakrabarti and S. K. Samantaray, Aust. N.Z. J. Med., 1976, 6, pp. 565–568. Fifty‐four patients with diabetic peripheral neuropathy were treated with carbamazepine for a period of one year. Clinical assessment and nerve conduction velocity studies (NCV) were done periodically. Forty‐nine patients had symptomatic relief of all sensory manifestations but NCV remained essentially unchanged. Untoward effects of the drug were frequent but transitory. It was concluded that carbamazepine is a dependable drug for the treatment of symptomatic diabetic sensory polyneuropathy.
No takes yet. Share an insight, caveat, or question.
Chakrabarti et al. (1976) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: